BioNTech SE (NASDAQ: BNTX) Share Price and News

$92.97 $1.27 (1.4%) Thursday, 28 March 2024 at 7:00:00 am Australian Eastern Daylight Time

BioNTech SE Chart and Price Data

About BioNTech Se

Last updated 28-03-2024, 07:00:00am AEDT
Current Price $92.97
Change $1.27 (1.4%)
Close Price $92.97
Open Price $92.38
Bid $92.93
Ask $93.25
Day Range $90.80 - $93.56
Year Range $85.21 - $131.52
Volume 1,764
Average Volume 691,177
Market Cap $22,101,386,200.00
Earnings Per Share $4.10
  • BioNTech SE (NASDAQ: BNTX)
    Latest News

    A nurse administers a vaccine into the arm of a woman wearing a mask.
    International Stock News

    2 Nasdaq stocks bucking Monday's market drop

    The Nasdaq Composite continued to lose ground, but these stocks held up.

    Read more »

    four excited doctors with their hands in the air
    ETFs

    Expert reveals top pandemic ETF play – up 58% in 12 months

    COVID variants are likely to drive longer-term demand for mRNA vaccines.

    Read more »

    A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
    Healthcare Shares

    Why the IDT (ASX:IDT) share price is rocketing 25% on Wednesday

    The company claims it can make 100 million doses of mRNA vaccine within 18 months.

    Read more »

    man receiving covid 19 vaccine moderna biontech
    International Stock News

    Better biotech stock: Moderna vs. BioNTech

    The two companies behind the gene-based COVID vaccines are a lot different than you might think.

    Read more »

    health care worker giving a woman a COVID 19 vaccine
    International Stock News

    With COVID-19 variant threats rising, why are vaccine stocks falling?

    Stock markets moved slightly higher despite general worries.

    Read more »

    woman receiving vaccine
    International Stock News

    3 reasons to buy BioNTech, and 1 reason to sell

    Despite the vaccine windfall and an impressive pipeline, shareholders might need the company's encore sooner than expected.

    Read more »

    Two laboratory researchers in white coats and gloves sit side by side with scientific equipment and a computer screen conducting medical related research.
    International Stock News

    Why BioNTech trounced the Market on Tuesday

    Shareholders might be getting a small present from the company before long.

    Read more »

    woman receiving covid 19 vaccine
    International Stock News

    If you thought these 2 big Nasdaq winners were done, think again

    On a strong day for the Nasdaq, two highfliers stood out.

    Read more »

    teen showing that she has received her covid vaccination
    International Stock News

    Moderna files for FDA approval of its COVID vaccine in teens

    The company hopes to secure Emergency Use Authorization for its vaccine in children ages 12 to 18.

    Read more »

    A medical researcher in a white coat holds laboratory equipment and smiles.
    International Stock News

    Moderna's teen COVID-19 vaccine trial hits high marks

    The company should submit its request for the FDA to authorize the use of its vaccine in those 12 and…

    Read more »

    vaccine
    International Stock News

    BioNTech is no longer a buy, says analyst

    A Bryan Garnier prognosticator increases her price target despite the recommendation chop.

    Read more »

    health prffesional giving someone a vaccine
    International Stock News

    Pfizer and BioNTech's COVID-19 vaccine authorized by the FDA for adolescents

    Parents are pleased, but the move won't change much for the drug companies from a financial perspective.

    Read more »

    Profile

    since

    Note